Showing results (191-200 of 619) with videos related to
Sort By:
Pageof 62
Rheumatology Advances in Practice|October 23, 2024
Support needs of gout patients and suitability of eHealth to address these needsJeffrey van der Ven, Bart J F van den Bemt, Floor Ariaans, et al.Rheumatology Advances in Practice|September 9, 2024
High-quality research on physical therapy in psoriatic arthritis is needed: a systematic reviewMarlies Kaerts, Thijs W Swinnen, Wim Dankaerts, et al.Rheumatology Advances in Practice|January 23, 2023
Spectrum of auto-inflammatory diseases in Morocco: a monocentric experienceManal Souali, Asmaa Sakhi, Ghita Benbrahim Ansari, et al.Rheumatology Advances in Practice|January 26, 2023
The role of microRNAs in regulating inflammation and exercise-induced adaptations in rheumatoid arthritisChristopher Balchin, Ai Lyn Tan, Oliver J Wilson, et al.Rheumatology Advances in Practice|December 23, 2022
Examining the safety of relaxed drug monitoring for methotrexate in response to the COVID-19 pandemicAbdulrahman Shadeed, Leila Kattach, Sharlene Sam, et al.Rheumatology Advances in Practice|November 27, 2019
Health-care professionals' perceptions of interacting with patients of South Asian origin attending early inflammatory arthritis clinicsKanta Kumar, Rebecca J Stack, Ade Adebajo, et al.Rheumatology Advances in Practice|July 29, 2021
Disease impact of rheumatoid arthritis in patients not treated with advanced therapies; survey findings from the National Rheumatoid Arthritis SocietyElena Nikiphorou, Hannah Jacklin, Ailsa Bosworth, et al.Rheumatology Advances in Practice|February 5, 2020
Work productivity loss among rheumatoid arthritis patients in India: a qualitative studyAvinash Jain, Amita Aggarwal, Jo Adams, et al.Rheumatology Advances in Practice|May 9, 2022
Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional studyMarwan Bukhari, Nicola Goodson, Maarten BoersRheumatology Advances in Practice|June 6, 2022
Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT studyGyörgy Nagy, Pál Géher, László Tamási, et al.Pageof 62